October 16, 2017October 16, 2017

Remetinostat’s Promising Results in Mycosis Fungoides Patients Presented at EORTC Meeting

News

Topical remetinostat 1% gel can significantly reduce the severity of skin lesions and itching in mycosis fungoides (MF) patients without systemic adverse events, data from a Phase 2 trial show. The ... Read more

April 17, 2017April 17, 2017

Remetinostat Gel Twice a Day Leads to 40% Skin Lymphoma Response Rate, Study Shows

News

Remetinostat gel applied twice a day led to partial or complete responses in 40 percent of patients with skin lymphoma, according to a Phase 2 clinical trial. The trial of ... Read more